Search News
| 7.28 Delayed Data As of Sep 21 |  -0.03 / -0.41%Today’s Change | 4.12 Today|||52-Week Range 8.13 | +48.27% Year-to-Date |
| Previous close | 7.31 |
| Today’s open | 7.28 |
| Day’s range | 7.19 - 7.56 |
| Volume | 1,978,555 |
| Average volume (3 months) | 786,681 |
| Market cap | $786.4M |
| Earnings growth (last year) | -4.00% |
| Earnings growth (this year) | -15.24% |
| Earnings growth (next 5 years) | +24.73% |
| Revenue growth (last year) | -4.43% |
| P/E ratio | NM |
| Price/Sales | 16.46 |
| Price/Book | 8.55 |
| Today’s change | Today’s % change | |
|---|---|---|
| URGNUrogen Pharma Ltd | +0.78 | +1.60% |
| FATEFate Therapeutics In... | +0.54 | +3.85% |
| FIXXHomology Medicines I... | +1.16 | +5.68% |
| RDUSRadius Health Inc | -0.90 | -4.78% |
| Next reporting date | November 8, 2018 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $25.2M |
| Annual profit (last year) | -$65.8M |
| Net profit margin | -261.18% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Jon P. Stonehouse |
Vice President-Investor Relations & Operations Robert Bennett |
Corporate headquarters Durham, North Carolina |
